Hudson Bay Capital Management
DTIL icon

Hudson Bay Capital Management’s Precision BioSciences DTIL Stock Holding History

Hudson Bay Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
+37,141
New +$171K ﹤0.01% 1099

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Hudson Bay Capital Management's DTIL Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Precision BioSciences (DTIL) in Q1 2026: 37,141 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #1099 among its holdings.

78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Hudson Bay Capital Management held 37,141 shares of Precision BioSciences worth $204K as of Q1 2026.
  • Precision BioSciences was a new Hudson Bay Capital Management position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1099 holding.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.